Senate grants the FDA a 6.5% raise in funding

Share this article:
The FDA's total funding for FY 2007 has been set at $1.942 billion--representing a 6.5%
increase over the previous year. The Senate Appropriations Committee reported out the agency's spending provision as part of the agriculture appropriations bill.

The measure includes “increases of $50.5 million for pandemic avian influenza preparedness, $8.6 million for medical device and animal drug review, $4.0 million for drug safety, $5.5 million for food safety, $10.0 million for generic drug review, $5.9 million for the Critical Path initiative, and $2.5 million for human tissue safety,” a committee release said.

It noted that the bill does not include language addressing the FDA's authority to require post-marketing studies of drugs, a provision dropped by the House when it passed its version in May.

The bill does, however, include language representing a compromise agreement requiring the FDA to provide advance notification about conflicts of interest waivers granted to outside experts impaneled as “special government employees” on FDA advisory committees, 15 days prior to committee meetings.

Share this article:

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.